Skip to main content

Modifications in the Chemical Composition and Thermometric Behavior of LDL and HDL by Probucol in Type IIa Hyperlipoproteinemia

  • Chapter
Eicosanoids, Apolipoproteins, Lipoprotein Particles, and Atherosclerosis

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 243))

Abstract

The role of low density (LDL) and high density (HDL) lipoproteins in cholesterol transport and the pathogenesis of coronary artery disease is widely known. Many studies have pointed out the importance of the physical chemical properties of these particles (1-2). In man, LDL from patients with familial hypercholesterolemia were larger and contained more cholesteryl esters and less triglycerides than the LDL from normal subjects (3,4,5). In animals, LDL from monkeys or swines fed an atherogenic diet were also large cholestery lester-enriched particles (6,7). Probucol is a lipid-lowering drug used in the management of hypercholesterolemia. The drug is transported primarily in lipoproteins, mostly LDL (8). Its mode of action remains unclear. Probucol treatment has been reported to decrease LDL and HDL cholesterol (9,10). The drug is effective in a high proportion of patients, including subjects with the heterozygous and homozygous forms of familial hypercholesterolemia (11,12) and in the receptor-deficient WHHL-rabbit (13). Kinetic studies of lipoprotein metabolism in animals (13) or in man (14,15) suggest that probucol might enhance LDL catabolism. This effect on the lipoprotein metabolism could be explained by a modification in lipoprotein composition and structure. This study is designed to investigate the effect of probucol treatment on the chemical composition and fluidity of LDL and HDL.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. A.R. Tall, D.M. Small, D. Atkinson, and J.L. Rudel, Studies on the structure of low density lipoproteins isolated from Macaca fascicularis fed anatherogenic diet, J. Clin. Invest. 62: 1354 (1978).

    Article  PubMed  CAS  Google Scholar 

  2. H.J. Pownall, R.L. Jackson, R.I. Roth, A.M. Gotto, J.R. Patsch, and F.A. Kummerow, Influence of an atherogenic diet on the structure of swine low density lipoproteins, J. Lipid Res. 21: 1108 (1980).

    PubMed  CAS  Google Scholar 

  3. W. Patsch, R. Ostlund, I. Kuisk, R. Levy, and G. Schonfeld, Characterization of lipoprotein in a kind red with familial hypercholesterolemia, J. Lipid. Res. 23:1196 (1982).

    PubMed  CAS  Google Scholar 

  4. A.V. Jardhav, and G.R. Thompson, Reversible abnormalities of low density lipoprotein composition in familial hypercholesterolemia, Europ. J. Clin. Invest. 9:63 (1979).

    Article  Google Scholar 

  5. B. Teng, G.R. Thompson, A.D. Snidermann, T.M. Forte, R.M. Krauss, and P.O. Kwiterovich, Composition and distribution of low density lipoprotein fractions inhyper-alpha-lipoproteinemia, normolipidemia and familial hypercholesterolemia, Proc.Ntl.Acad.Sci.USA, 80:6662 (1988).

    Article  Google Scholar 

  6. L.L. Rudel, M.G. Bond, and B.C. Bullock, LDL heterogeneity and atherosclerosis in non human primate, Ann.N.Y.Acad.Sci. 454:248 (1985).

    Article  PubMed  CAS  Google Scholar 

  7. A.R. Tall, D. Atkinson, D.M. Small, and R.W. Mahley, Characterisation of the lipoproteins of atherosclerotic swine, J. Biol. Chein. 252:7288 (1977).

    CAS  Google Scholar 

  8. C. Dachet, B. Jacotot, and J.C. Buxtorf, The hypolipidemic action of Probucol. Drug transport and lipoprotein composition in type Ila hyperlipoproteinemia, Atherosclerosis 58:261 (1985).

    Article  PubMed  CAS  Google Scholar 

  9. J. Lelorier, S. Dubreuil-Quidoz, S. Lussier-Cacan, Y.S. Huang and J. Davignon, Diet and Probucol in lowering cholesterol concentrations, Arch.Intern.Med. 137:1429 (1977).

    Article  PubMed  CAS  Google Scholar 

  10. M.J. Mellies, P.S. Gartside, L. Glatfelter, F. Vink, G. Guy, G. Schonfeld, and G.T. Glueck, Effect of probucol on plasma cholesterol, high and low density lipoprotein cholesterol and apoproteins A-I and A-II in adults with primary familial hypercholesterolemia, Metabolism 29:956 (1980).

    Article  PubMed  CAS  Google Scholar 

  11. S.G. Baker, B.I. Joffe, D. Mendelsohn, and H.C. Seftel, Treatment of homozygous familial hypercholesterolemia with probucol, S. Afr. Med. J. 62:7 (1982).

    PubMed  CAS  Google Scholar 

  12. A. Yamamoto, Y. Matsuzawa, B. Kishino, R. Hayashi, K. Hirobe, and T. Kikkawa, Effects of Probucol on homozygous cases of familial hypercholesterolemia, Atherosclerosis 48:157 (1983).

    Article  PubMed  CAS  Google Scholar 

  13. M. Naruszewicz, T.E. Carew, R.C. Pittman, J.L. Witztum, and D. Steinberg, A novel mechanism by which J Probucol lowers low density lipoprotein levels demonstrated in the LDL receptor deficient rabbit, J. Lipid Res. 25:1206 (1984).

    PubMed  CAS  Google Scholar 

  14. P.J. Nestel, and T. Billington, Effects of probucol on low density lipoprotein removal and high density lipoprotein synthesis, Atherosclerosis 38:203 (1981).

    Article  PubMed  CAS  Google Scholar 

  15. Y.A. Kesaniemi, and S.M. Grundy, Influence of probucol on cholesterol and lipoprotein metabolism in man, J. Lipid Res. 25:780 (1984).

    PubMed  CAS  Google Scholar 

  16. L.L. Rudel, and L.L. Pitts, Male female variability in the dietary cholesterol induce dhyperlipoproteinemia of Cynomolgus monkeys (Macacafascicularis), J. Lipid Res. 19:992 (1978).

    PubMed  CAS  Google Scholar 

  17. R.W. St.Clair, P. Greenspan and M.Leight, Enhanced cholesterol delivery to cells in culture by low density lipoproteins from hypercholesterolemic monkeys. Correlation of cellular cholesterol accumulation with low density lipoprotein molecular weight. Arteriosclerosis 3:77 (1983).

    Article  PubMed  CAS  Google Scholar 

  18. S. Eisenberg, High density lipoprotein metabolism, J. Lipid Res. 25:1017 (1984).

    PubMed  CAS  Google Scholar 

  19. J. Ihm, D.M. Quinn, S.J. Busch, B.Chataing, and S.A.K. Harmony, Kinetics of plasma protein-catalyzed exchange of phosphatidylcholine and cholestery lester between plasma lipoproteins, J. Lipid Res. 23: 1328 (1982).

    PubMed  CAS  Google Scholar 

  20. S. Parthasarathy, S.G. Young, J.L. Witztum, R.C. Pittman, and D. Steinberg, Probucol inhibits oxidative modification of low density lipoprotein, J. Clin. Invest. 77:641 (1985).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Plenum Press, New York

About this chapter

Cite this chapter

Dachet, C., Motta, C., Neufcour, D., Jacotot, B. (1988). Modifications in the Chemical Composition and Thermometric Behavior of LDL and HDL by Probucol in Type IIa Hyperlipoproteinemia. In: Malmendier, C.L., Alaupovic, P. (eds) Eicosanoids, Apolipoproteins, Lipoprotein Particles, and Atherosclerosis. Advances in Experimental Medicine and Biology, vol 243. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0733-4_22

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-0733-4_22

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8055-2

  • Online ISBN: 978-1-4613-0733-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics